LCAT and metabolic syndrome: Because of the coherent reduction in LCAT activity and its product-to-substrate ratios in MetS, we sought to understand the extent to which these parameters correlated with characteristic metabolic risk factors linked to MetS, such as BMI, HOMA2-IR, and HDL-C.